SUMMARY The expression of the lymphoid marker, common leucocyte antigen and of the epithelial marker, epithelial membrane antigen by small cell anaplastic thyroid tumours was studied in 53 tumours, using the peroxidase-antiperoxidase and avidin-biotin techniques. Common leucocyte antigen was found in 33 of the 53 tumours; six tumours were positive for epithelial membrane antigen; and the remaining 14 tumours were negative for both markers. These results support the suggestion that most small cell anaplastic thyroid tumours are of lymphoid origin. Survival data for patients with tumours positive for common leucocyte antigen showed a significantly better prognosis than did the data for patients with small cell tumours that did not express this marker (p < 0-02).
Small cell anaplastic tumours account for 15% of all thyroid malignancies. ' The histogenesis of such tumours has been the subject of considerable debate,2 but they are now considered to be of lymphoid or epithelial origin,3 lymphomas being the more common.34 It is often impossible for the histopathologist, however, to distinguish between the two groups on morphological grounds alone. Histological criteria for this distinction have been outlined5 but are often difficult to apply, particularly when specimens obtained by needle biopsy are being dealt with.
The clinical importance of distinguishing between lymphoma and anaplastic carcinoma remains uncertain. It has been suggested that lymphomas respond more favourably to radiotherapy and have a better prognosis than anaplastic carcinomas.6 Much of the evidence for this is anecdotal, however, and in a large retrospective study Rossi et al found no significant difference in survival between the two groups.7 In their study Rossi and Nine out of 10 well differentiated thyroid carcinomas showed strong positive staining for epithelial membrane antigen, with weak focal positivity in the remaining case. This antigen was distributed in a pattern similar to that seen in normal thyroid tissue, with maximal staining on the cell membrane along the luminal border. All 10 tumours showed positive staining for thyroglobulin. None was positive for common leucocyte antigen.
ANAPLASTIC TUMOURS
Six of the 53 anaplastic tumours were positive for epithelial membrane antigen. This was predominantly distributed in bound linear membranes ( Fig. 1 ), though in three cases sporadic tumour cells showed diffuse intracytoplasmic staining. Thyroglobulin was not detected in the anaplastic tumours. Thirty three tumours were positive for common leucocyte antigen. Staining for this antigen was exclusively linear membrane bound ( antigen and epithelial membrane antigen five months. Kaplan Meier survival curves for patients with tumours positive for common leucocyte antigen were compared with those for patients with tumours negative for common leucocyte antigen (Fig. 3) In this study we used common leucocyte antigen as a lymphoid cell marker and epithelial membrane antigen as an epithelial cell marker. Such a combination has been used in the differential diagnosis of large cell anaplastic tumours." Common leucocyte antigen is a cell membrane protein that is present on all leucocytes and well differentiated lymphomas. '2 Thirty three tumours in our study (62%) expressed this antigen, thus supporting the theory that most small cell thyroid tumours are lymphomas.4 Epithelial membrane antigen is also a membrane bound antigen, which is expressed on a wide range of epithelial cells and also on mesothelial cells. '3 In their study Sloane et al showed that epithelial membrane antigen was expressed by well differentiated thyroid carcinomas. '3 In our study we confirmed this, finding strong staining for this antigen in nine out of 10 tumours; however, epithelial membrane antigen was found in only six anaplastic tumours. None of these tumours coexpressed common leucocyte antigen, and we consider that they may therefore be regarded as probable epithelial tumours. Delsol et al recently questioned the specificity of epithelial membrane antigen for epithelial cells and confirmed its presence on plasma cells.'4 These cells, however, would be expected to coexpress common leucocyte antigen, and any tumour that exclusively expressed epithelial membrane antigen might be considered to be of probable epithelial origin. The lack of expression of thyroglobulin by the anaplastic tumours affirms the result of previous studies. '5 On the basis of our immunohistochemical results, therefore, we reclassified 16 (30%) of our retrospective series of anaplastic small cell carcinomas. The ease with which the immunohistochemical technique can be applied on material embedded in paraffin means that antibodies to common leucocyte antigen and epithelial membrane antigen should be useful diagnostic tools in the investigation of anaplastic thyroid tumours. There remains a group of tumours, however, that express neither epithelial membrane antigen nor common leucocyte antigen. The histogenesis of these undifferentiated tumours remains uncertain.
It has often been suggested that thyroid lymphomas respond more readily to radiotherapy and have a better prognosis than small cell carcinomas. 4'10 There have been few studies in which survival data for the two groups have been compared: Rossi et al studied 147 anaplastic thyroid tumours and divided these into small cell compact carcinomas, small cell diffuse carcinomas, and lymphomas on the basis of their histological appearances.7 One and five year survival figures were used in the analysis of the data. They showed no significant difference in survival between the patients with small cell diffuse carcinoma and those with lymphoma, though the patients with small cell compact carcinoma showed a poorer five year survival. These results must be interpreted with caution, given the accepted limitations of histological criteria in distinguishing between lymphomas and carcinomas.
In this study we compared survival curves for patients with common leucocyte antigen positive tumours with those for patients with common leucocyte antigen negative tumours using Kaplan 
